Market Overview:
The global nootropics market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising awareness about the benefits of nootropics, increasing demand for cognitive enhancers, and growing popularity of brain-training games. However, stringent regulatory norms and lack of standardization are some factors that could hamper the growth of this market. The global nootropics market is segmented on the basis of type, application, and region. On the basis of type, it is divided into attention and focus supplements, memory enhancement supplements, mood and depression supplements, sleep and anxiety supplements, and others (including energy boosters and weight loss supplements). On the basis of application it is classified into adult applications (such as students) and kid applications (such as toddlers). Region wise it covers North America (the U.S., Canada), Latin America (Brazil), Europe (Germany), Asia Pacific excluding Japan) Japan), Middle East & Africa(South Africa).
Product Definition:
Nootropics are drugs, supplements, or other substances that improve cognitive function. The use of nootropics is growing in popularity as people seek to improve their focus, memory, and mental clarity. Nootropics are important for students who want to achieve peak performance in school and professionals who want to stay sharp during intense work periods.
Attention and Focus:
Attention and focus are two separate yet interrelated aspects of human consciousness. While attention is the cognitive process of focusing on a particular object or region in our surroundings, focus is the mental state when we are able to maintain awareness for a particular task.
The ability to control one’s attention is considered as an important skill for success in any field such as education, sports, and business.
Memory Enhancement:
Memory enhancement is the process through which the body’s cells, tissues and organs are stimulated to grow and develop more quickly. It helps in improving memory, attention span & concentration as well as it enhances learning ability. The nootropic drugs help in enhancing memory by improving blood flow to the brain, increasing acetylcholine (ACh) levels in the brain or by blocking enzymes that break down ACh.
Application Insights:
The adult application segment dominated the global nootropics market in 2017. This can be attributed to the growing preference for smart drugs by working professionals to help them perform at their best. The memory enhancement type of nootropics is most commonly used by adults as it helps in improving short-term and long-term memory, concentration and learning abilities.
The kid application segment is expected to witness significant growth over the forecast period owing to rising usage of smart drugs for academic performance among school children and students from elementary level till graduation. The increasing use of these supplements among schoolchildren and students from elementary level till graduation can be attributed to improved academic performance along with enhanced concentration and mental alertness in a span of 2-3 hours after taking a dose. These are available without prescription, which makes them easily accessible even though health experts recommend against its consumption until age 18 years or above due largely due to lack of clinical evidence regarding its safety for human consumption beyond that age group.
Regional Analysis:
North America dominated the global nootropics market in 2016. The region is expected to maintain its position during the forecast period. This can be attributed to increasing R&D investments, rising adoption of smart drugs, and growing focus on mental wellbeing among individuals belonging to various socio-economic groups and age groups in the region.
Asia Pacific is anticipated to witness significant growth over the next eight years owing to increasing awareness about brain health and functioning among consumers from China, Japan, Singapore, South Korea & India who form a large part of this regional market due to their high purchasing power.
The European market also contributed significantly towards revenue generation in 2016 as it was one of the first regions where products were launched after North America & Asia Pacific markets had been well defined by manufacturers & end users respectively.
Growth Factors:
- Increasing awareness about the benefits of nootropics and their potential to improve cognitive function.
- Growing demand from students and professionals for products that can help them boost productivity and focus.
- Rising popularity of nootropic stacks, which allow users to customize their own cognitive enhancement regimens.
- Proliferation of online retailers selling nootropic supplements at competitive prices.
Scope Of The Report
Report Attributes
Report Details
Report Title
Nootropics Market Research Report
By Type
Attention and Focus, Memory Enhancement, Mood and Depression, Sleep and Anxiety, Others
By Application
Adult, Kid
By Companies
Nootrobox, Cephalon, Purelife Bioscience, Peak Nootropics, Nootrico, SupNootropic Biological Technology, AlternaScript, Accelerated Intelligence, Onnit Labs, Powder City, Ceretropic, Nootropic Source, Clarity Nootropics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Nootropics Market Report Segments:
The global Nootropics market is segmented on the basis of:
Types
Attention and Focus, Memory Enhancement, Mood and Depression, Sleep and Anxiety, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Adult, Kid
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Nootrobox
- Cephalon
- Purelife Bioscience
- Peak Nootropics
- Nootrico
- SupNootropic Biological Technology
- AlternaScript
- Accelerated Intelligence
- Onnit Labs
- Powder City
- Ceretropic
- Nootropic Source
- Clarity Nootropics
Highlights of The Nootropics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Attention and Focus
- Memory Enhancement
- Mood and Depression
- Sleep and Anxiety
- Others
- By Application:
- Adult
- Kid
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nootropics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Nootropics are a class of supplements that aim to improve cognitive function. They can be divided into two categories: those that act as “smart drugs” and those that work more like traditional vitamins. Nootropics in the smart drug category include substances like piracetam, aniracetam, and oxiracetam. These ingredients help to improve memory and focus, while also reducing anxiety and improving moods. Nootropics in the vitamin category include B-vitamins (such as B12) and omega-3 fatty acids (such as EPA). These nutrients have been shown to support cognitive function in studies by improving memory recall or working better together with other brain-boosting supplements.
Some of the major players in the nootropics market are Nootrobox, Cephalon, Purelife Bioscience, Peak Nootropics, Nootrico, SupNootropic Biological Technology, AlternaScript, Accelerated Intelligence, Onnit Labs, Powder City, Ceretropic, Nootropic Source, Clarity Nootropics.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Nootropics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Nootropics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Nootropics Market - Supply Chain
4.5. Global Nootropics Market Forecast
4.5.1. Nootropics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Nootropics Market Size (000 Units) and Y-o-Y Growth
4.5.3. Nootropics Market Absolute $ Opportunity
5. Global Nootropics Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Nootropics Market Size and Volume Forecast by Type
5.3.1. Attention and Focus
5.3.2. Memory Enhancement
5.3.3. Mood and Depression
5.3.4. Sleep and Anxiety
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Nootropics Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Nootropics Market Size and Volume Forecast by Application
6.3.1. Adult
6.3.2. Kid
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Nootropics Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Nootropics Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Nootropics Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Nootropics Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Nootropics Demand Share Forecast, 2019-2029
9. North America Nootropics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Nootropics Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Nootropics Market Size and Volume Forecast by Application
9.4.1. Adult
9.4.2. Kid
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Nootropics Market Size and Volume Forecast by Type
9.7.1. Attention and Focus
9.7.2. Memory Enhancement
9.7.3. Mood and Depression
9.7.4. Sleep and Anxiety
9.7.5. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Nootropics Demand Share Forecast, 2019-2029
10. Latin America Nootropics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Nootropics Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Nootropics Market Size and Volume Forecast by Application
10.4.1. Adult
10.4.2. Kid
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Nootropics Market Size and Volume Forecast by Type
10.7.1. Attention and Focus
10.7.2. Memory Enhancement
10.7.3. Mood and Depression
10.7.4. Sleep and Anxiety
10.7.5. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Nootropics Demand Share Forecast, 2019-2029
11. Europe Nootropics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Nootropics Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Nootropics Market Size and Volume Forecast by Application
11.4.1. Adult
11.4.2. Kid
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Nootropics Market Size and Volume Forecast by Type
11.7.1. Attention and Focus
11.7.2. Memory Enhancement
11.7.3. Mood and Depression
11.7.4. Sleep and Anxiety
11.7.5. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Nootropics Demand Share, 2019-2029
12. Asia Pacific Nootropics Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Nootropics Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Nootropics Market Size and Volume Forecast by Application
12.4.1. Adult
12.4.2. Kid
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Nootropics Market Size and Volume Forecast by Type
12.7.1. Attention and Focus
12.7.2. Memory Enhancement
12.7.3. Mood and Depression
12.7.4. Sleep and Anxiety
12.7.5. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Nootropics Demand Share, 2019-2029
13. Middle East & Africa Nootropics Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Nootropics Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Nootropics Market Size and Volume Forecast by Application
13.4.1. Adult
13.4.2. Kid
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Nootropics Market Size and Volume Forecast by Type
13.7.1. Attention and Focus
13.7.2. Memory Enhancement
13.7.3. Mood and Depression
13.7.4. Sleep and Anxiety
13.7.5. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Nootropics Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Nootropics Market: Market Share Analysis
14.2. Nootropics Distributors and Customers
14.3. Nootropics Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Nootrobox
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Cephalon
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Purelife Bioscience
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Peak Nootropics
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Nootrico
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. SupNootropic Biological Technology
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. AlternaScript
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Accelerated Intelligence
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Onnit Labs
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Powder City
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Ceretropic
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Nootropic Source
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Clarity Nootropics
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
